GMPPX
Price
$38.83
Change
+$0.20 (+0.52%)
Updated
Oct 17 closing price
Net Assets
1.09B
VIMAX
Price
$358.27
Change
+$0.63 (+0.18%)
Updated
Oct 17 closing price
Net Assets
201.28B
Interact to see
Advertisement

GMPPX vs VIMAX

Header iconGMPPX vs VIMAX Comparison
Open Charts GMPPX vs VIMAXBanner chart's image
Goldman Sachs Mid Cap Value P
Price$38.83
Change+$0.20 (+0.52%)
VolumeN/A
Net Assets1.09B
Vanguard Mid Cap Index Admiral
Price$358.27
Change+$0.63 (+0.18%)
VolumeN/A
Net Assets201.28B
GMPPX vs VIMAX Comparison Chart in %
View a ticker or compare two or three
VS
GMPPX vs. VIMAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMPPX is a StrongBuy and VIMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 201B vs. GMPPX (1.09B). VIMAX pays higher dividends than GMPPX: VIMAX (1.48) vs GMPPX (0.95). GMPPX was incepted earlier than VIMAX: GMPPX (8 years) vs VIMAX (24 years). GMPPX (0.83) is less costly to investors than VIMAX (0.05). GMPPX is a more actively managed with annual turnover of: 56.00 vs. VIMAX (16.00). GMPPX has a lower initial minimum investment than VIMAX: GMPPX (0) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 7.58 vs. GMPPX (-2.42). VIMAX return over 5 years is better than : 57.32 vs. GMPPX (22.36).
GMPPXVIMAXGMPPX / VIMAX
Total Expense Ratio0.830.051,660%
Annual Report Gross Expense Ratio0.830.051,660%
Fund Existence8 years24 years-
Gain YTD6.3849.70766%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.09B201B1%
Annual Yield % from dividends0.951.4864%
Returns for 1 year-2.427.58-32%
Returns for 3 years13.7049.7028%
Returns for 5 years22.3657.3239%
Returns for 10 yearsN/A140.93-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVX1.980.02
+1.02%
NOVONIX Limited
CXM7.620.05
+0.66%
Sprinklr
ATIIU10.59N/A
N/A
Archimedes Tech SPAC Partners II Co
ABVC2.92N/A
N/A
ABVC BioPharma
MDGL438.90-3.23
-0.73%
Madrigal Pharmaceuticals